Product Information
SANCUSO 3.1 MG/24 HR PATCH is a brand product labeled by Cumberland Pharmaceuticals Inc., priced at $685.8523 per EA under NDC 66220063731. Its NADAC has been published 114 times since Jul 31, 2024.
FDA first approved this application on Sep 12, 2008.
Strength
3.1 mg/24h
Manufacturer
Cumberland Pharmaceuticals Inc.NDC
66220063731
Classification
Brand
Dosage Form
PATCH
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
GRANISETRONApproval Type
New Drug (NDA)
FDA Application
NDA022198FDA Approved
9/12/2008
On Market Since
7/16/2024
Pharmacological Classes
Price Statistics
The NADAC for SANCUSO 3.1 MG/24 HR PATCH has been published 114 times since Jul 31, 2024, and over the history we have for it it has risen 7.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $685.8523 per EA |
|---|---|
| All-time high | $688.8205 (Aug 12, 2026) |
| All-time low | $634.5738 (Aug 21, 2024) |
| 52-week high | $688.8205 |
| 52-week low | $655.3031 |
| Median price | $655.3031 |
| Average price | $658.8529 |
| Largest weekly change | +3.0% (Jan 1, 2025) |
| Weeks tracked | 114 |
| Tracking since | Jul 31, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the granisetron market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cumberland Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
granisetron market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-3 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SANCUSO 3.1 MG/24 HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for SANCUSO 3.1 MG/24 HR PATCH, manufactured by Cumberland Pharmaceuticals Inc., is $685.8523 per EA (NDC 66220063731), effective Sep 30, 2026.
How has the price of SANCUSO 3.1 MG/24 HR PATCH changed over time?
Over the history we have for it, the NADAC for SANCUSO 3.1 MG/24 HR PATCH has risen 7.8%. It has been tracked across 114 weekly CMS publications since Jul 31, 2024.
What are the highest and lowest recorded NADAC prices for SANCUSO 3.1 MG/24 HR PATCH?
Since Jul 31, 2024, the NADAC for SANCUSO 3.1 MG/24 HR PATCH has ranged from a low of $634.5738 (Aug 21, 2024) to a high of $688.8205 (Aug 12, 2026), with a median of $655.3031 per EA.
Are there cheaper alternatives to SANCUSO 3.1 MG/24 HR PATCH?
No other NADAC-published product currently shares the active ingredient and strength of SANCUSO 3.1 MG/24 HR PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SANCUSO 3.1 MG/24 HR PATCH?
SANCUSO 3.1 MG/24 HR PATCH (NDC 66220063731) is labeled by Cumberland Pharmaceuticals Inc., and CMS classifies it as a brand product.